Skip to content
Bright Minds Biosciences episode artwork

Aug 23, 2021 17 min

Bright Minds Biosciences

from OTCQB Podcast Hosted by OTC Markets Group

Bright Minds Biosciences (OTCQB: BMBIF), is a biotechnology company focused on developing novel treatments for neuropsychiatry disorders, epilepsy and pain. Dr. Gideon Shapiro, Vice President of Discovery joins us to discuss the safety and efficacy of psychedelic treatments and how Bright Minds' treatments differ from conventional medicine. View Podcast Transcript for Bright Minds Biosciences

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Bright Minds Biosciences

0:00 17:26

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OTCQB Podcast?

This episode is 17 minutes long.

When was this OTCQB Podcast episode published?

This episode was published on August 23, 2021.

Can I download this OTCQB Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.